Baylor University Medical Center Obstetrics and Gynecology

Topics

• Pelvic floor disorders treatments 22
• Organ and Tissue Transplantation Research 16
• Maternal and fetal healthcare 10
• Immunotherapy and Immune Responses 9
• HER2/EGFR in Cancer Research 8
• Cancer Immunotherapy and Biomarkers 7
• Ectopic Pregnancy Diagnosis and Management 7
• Gynecological conditions and treatments 7
• HIV/AIDS Research and Interventions 7
• Ovarian cancer diagnosis and treatment 7
• Pregnancy and preeclampsia studies 5
• Chronic Lymphocytic Leukemia Research 4

Most cited

1. Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.

   The New England journal of medicine · 2023 · 448 citations · Minal Barve

2. Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 271 citations · Minal Barve

3. Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.

   Lancet (London, England) · 2021 · 391 citations · Minal Barve

4. First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1).

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 277 citations · Minal Barve

5. Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer.

   Cancer discovery · 2024 · 117 citations · Minal Barve

6. Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.

   The New England journal of medicine · 2026 · 24 citations · Minal Barve